Danaher Corp Stock Forecast for 2023 - 2025 - 2030
Updated on 09/26/2023
Danaher Corp Stock Forecast and Price Target
The average target price for Danaher Corp's stock set by renowned analysts in recent months is $304.50, representing a potential upside of approximately 20.81% from its last closing price if met by 2024. This estimation is based on a high estimate of $365.00 and a low estimate of $242.00. Although you may not be interested in DHR stock, you should still be aware of its competitors.
20.81% Upside
Danaher Corp Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's Price has grown, moving from $135.25 to $299.88 – an increase of 121.72%. In the next year, analysts predict that Fair Value will jump to $334.15 – up 11.43% from the current level. Looking ahead to eight years, experts forecast that Fair Value will grow by 60.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific Inc | Outperform |
10
|
$505.66 | Buy/Sell | $625.63 | 22.61% |
| A Stock Forecast | Agilent Technologies | Outperform |
17
|
$111.94 | Buy/Sell | $141.56 | 48.74% |
| ILMN Stock Forecast | Illumina Inc | Outperform |
16
|
$131.41 | Buy/Sell | $254.08 | 89.86% |
| MTD Stock Forecast | Mettler-Toledo International I... | Hold |
13
|
$1.12k | Buy/Sell | $1.39k | 21.61% |
| WAT Stock Forecast | Waters Corp | Hold |
15
|
$271.12 | Buy/Sell | $302.88 | 25.41% |
Danaher Corp Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's Revenue has grown, moving from $17.91B to $31.47B – an increase of 75.71%. In the next year, analysts predict that Revenue will jump to $32.27B – up 2.53% from the current level. Looking ahead to eight years, experts forecast that Revenue will grow by 25.61%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$39.91 | Buy/Sell | $159.83 | 307.17% |
| AVTR Stock Forecast | Avantor | Buy |
16
|
$21.01 | Buy/Sell | $0.00 | 114.18% |
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$353.18 | Buy/Sell | $606.00 | 64.93% |
.jpg)
Danaher Corp Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's Dividend per Share has seen an increase, rising from $0.68 to $1.08. This represents a growth of 58.82%. Analysts predict that Danaher Corp's Dividend per Share will increase in the upcoming year, reaching $1.12. This would represent an increase of 3.70%. Over the next eight years, experts predict that Danaher Corp's Dividend per Share will grow at a rate of 62.16%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRKR Stock Forecast | Bruker Corp | Outperform |
16
|
$62.86 | Buy/Sell | $72.11 | 19.31% |
| COHR Stock Forecast | Coherent | Hold |
12
|
$33.55 | Buy/Sell | $255.33 | 756.60% |
| PACB Stock Forecast | Pacific Biosciences of Califor... | Outperform |
9
|
$8.46 | Buy/Sell | $17.33 | 95.04% |
Danaher Corp Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Free Cash Flow for Danaher Corp has grown by 214317924.19%, going from $3.32B to $7107.00T. In the following year, 8 experts forecast Danaher Corp's Free Cash Flow will decrease by 100.00%, to $8.05B. In 2030, professionals predict that Danaher Corp's Free Cash Flow will decrease by 100.00%, to $10.50B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FLDM Stock Forecast | Fluidigm | - |
11
|
$20.37 | Buy/Sell | $12.00 | -91.31% |
| HBIO Stock Forecast | Harvard Bioscience | Buy |
14
|
$4.57 | Buy/Sell | $10.00 | 118.82% |
| EQTL Stock Forecast | Equitech International | - |
0
|
$2.00 | Buy/Sell | $0.00 | -100.00% |
Danaher Corp Net Income Forecast for 2023 - 2025 - 2030
Danaher Corp's Net Income has seen growth In the last three years, going from $3.01B to $7.21B – a gain of 139.64% In the next year, analysts believe that Net Income will reach $8.05B – an increase of 11.60%. For the next eight years, the forecast is forNet Income to grow by 40.91%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OMRX Stock Forecast | Orthometrix | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| LFPI Stock Forecast | LifePoint | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| MDIT Stock Forecast | Medite Cancer Diagnostics | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Danaher Corp EBITDA Forecast for 2023 - 2025 - 2030
Danaher Corp's EBITDA has grown in the last three years, jumping from $4.47B to $10.73B – an increase of 139.88%. In the next year, analysts predict that EBITDA will reach $11.18B – an increase of 4.29%. For the next eight years, the forecast is for EBITDA to grow by 27.72%.
Danaher Corp EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Danaher Corp's EBIT has increased by 148.92%, going from $3.28B to $8.17B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $8.73B – an increase of 6.86%. The Danaher Corp forecast is for EBIT to reach $11.08B or grow by 35.66%.
Danaher Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Danaher Corp's EPS has grown, moving from $4.42 to $9.80 – an increase of 121.72%. In the next year, analysts predict that EPS will jump to $10.92 – up 11.43% from the current level. Looking ahead to eight years, experts forecast that EPS will grow by 60.93%.
.jpg)